Polyneuron Pharmaceuticals
Most recently Dr. Barker was Chief Medical and Development Officer of Polyphor during the period the company listed on the Swiss stock exchange. Prior to Polyphor, Dr. Barker held several senior roles at Novartis, including positions in oncology and infectious disease & immunology. She has also held several positions at Roche, including designing clinical studies for immunology drug development. She is currently on the board of the anti-infectives company Destiny Pharma and BerGenBio, an immuno-oncology company based in Norway. Dr. Barker received her medical training from Cambridge University, UK.
This person is not in any offices
Polyneuron Pharmaceuticals
2 followers
Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-Catch™ technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs.